2m 2m 2m 2m 2m 2m 2m
INCANNEX HEAL (IXHL)
NASDAQ
$2.01-$0.01 (-0.50%)
Price as of Nov 13, 2026 2:02 PM EST- $25.3MMarket Cap
- -81.14%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
INCANNEX HEAL (IXHL)
$2.01-$0.01 (-0.50%)
IXHL | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $2.02 | ||
Change | +$0.04 (+2.28%) | ||
Open | $1.96 | ||
High | $2.06 | ||
Low | $1.96 | ||
Previous Close | $1.98 | ||
Volume | 104,350 | ||
30-Day Average Volume | 80,444 | ||
1-Week Change | -11.01% | ||
1-Month Change | -30.34% | ||
1-Year Change | -81.14% | ||
3-Year Change | -93.96% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 12.5M | ||
Total Assets | $70.4M | ||
Market Cap | $25.3M | ||
Enterprise Value | -$42.9M | ||
Period: QTR TTM FY | |||
Revenue | $0.00 | ||
Net Income | -$1.9M | ||
Free Cash Flow | $521,000.00 | ||
EBIT | -$1.9M | ||
EBITDA | -$1.9M | ||
Net Working Capital | $69.2M | ||
EPS | -$0.15 | ||
Enterprise Value/EBITDA | 22 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 0 | ||
P/E | -13 | ||
PEG | 0 | ||
Price/Free Cash Flow | 49 | ||
Price/Operating Cash Flow | 49 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 30 | ||
Last Split Date | 02/27/2026 | ||
Earnings & Revenue